Follow the entities shaping the evidence.

…inolones. For UTIs, 18.65%, 18.18% and 25.68% were treated with fosfomycin trometamol; 16.08%, 13.42% and 11.67% with fluoroquinolones; and 4.82%, 6.…

…a-blockers are indicated for chronic heart failure. Bisoprolol, metoprolol, carvedilol, and nebivolol are the beta-blockers that have an a…

…rbazepine, phenobarbital, phenytoin, topiramate, valproate, and zonisamide. The reference group consisted of pregnant patients with diagno…

… rheumatologists from the hospital’s electronic records system. SLE patients who met the 1990 American College of Rheumatology (ACR…

…age range. The long decline in the proportions of deaths due to ischaemic heart disease among people with epilepsy ended after 2011, despite continuing…

…what the concept of ‘care coordination’ actually encompasses.13 Cancer care coordination models Various models of coordinated care hav…

…esulting in a relatively smaller overall impact.Conclusions The COVID-19 epidemic demonstrated the most pronounced suppressive effect on…

…izumab had higher AE incidence without additional efficacy over pembrolizumab alone. Safety results were overall consistent with the known sa…

…as 23.3 for ccRCC (kidney), 1.9 for DLBCL (spleen), and 3.6 for MESO (lung). In comparative analyses, CD70 expression in ccRCC was s…

… (r/rMM). Two BCMA-targeted CAR T cell therapies, cilta-cel and ide-cel, have received FDA approval and have demonstrated deep initial …

…l be ‘lost’ on resistant pts (~85%) due to receiving at least 2 ICI cycles to enable response evaluation. Furthermore, the ‘non-res…

…Background Prostate cancer, a leading cause of cancer-related death in men, is refractory …